Stem cell transplantation for inflammatory bowel disease: Practical and ethical issues

Gut

Volumn 46, Issue 6, 2000, Pages 869-872

  Hawkey, C J ^a   Snowden, J A ^b   Lobo, A ^b   Beglinger, C ^c   Tyndall, A ^c  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

THYMOCYTE ANTIBODY;

ALLOTRANSPLANTATION; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW PURGING; CROHN DISEASE; ENTERITIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL ETHICS; METHODOLOGY; PATIENT INFORMATION; PATIENT RIGHT; PATIENT SELECTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; ULCERATIVE COLITIS; WHOLE BODY RADIATION;

HEALTH CARE AND PUBLIC HEALTH;

ETHICS, MEDICAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLAMMATORY BOWEL DISEASES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034126853     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.6.869     Document Type: Article

References (38)

1. 1 Marmont AM, Van Bekkum DW. Stem cell transplantation for severe autoimmune diseases: new proposals but still unanswered questions. Bone Marrow Transplant 1995;16:497-8.
2. 2 Tyndall A, Gratwohl A. Hemopoietic blood and marrow transplants in the treatment of severe autoimmune disease. Curr Opin Hematol 1997;4:390-4
3. 3 Burt RK. Immune ablation and hematopoietic stem cell rescue for severe autoimmune diseases. Cancer Treat Res 1997;77:317-32.
4. 4 Snowden JA, Brooks PM, Biggs JC. Haemopoietic stem cell transplantation for autoimmune diseases. Br J Haematol 1997;99:9-22.
5. 5 Marmont AM. Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases. J Rheumatol 1997;48(suppl): 13-8.
6. 6 Van Bekkum DW. Autologous stem cell therapy for treatment of autoimmune diseases. Exp Hematol 1998;26:831-4.
7. 7 Potter M, Black C, Berger A. Bone marrow transplantation for autoimmune diseases. BMJ 1999;318:750-1.
8. 8 Lopez-Cubero SO, Sullivan KM, McDonald GB. Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology 1998;114;433-40.
9. 9 Kashyap A. Forman SJ. Autologous bone marrow transplantation for non-Hodgkin's lymphoma resulting in long-term remission of coincidental Crohn's disease. Br J Haematol 1998;103:651-2.
10. 10 Soutar RL, King DJ. Bone marrow transplantation. BMJ 1995;310:31-6.
11. 11 Duncombe A. ABC of clinical haematology. Bone marrow and stem cell transplantation. BMJ 1997;314:1179-82.
12. 12 Tyndall A, Black C, Finke J, et al. Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet 1997;349:254.
13. 13 Snowden JA, Kearney P, Kearney A, et al. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 1998;41:453-9.
14. 14 Marmont AM, van Lint MT, Gualandi F, Bacigalupo A. Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus 1997;6:545-8.
15. 15 Burt RK, Traynor AE, Cohen B, et al. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant 1998;21:537-41.
16. 16 Martini A, Maccario R, Ravelli A, et al. Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis. Arthritis Rheum 1999;42:807-11.
17. 17 Snowden JA, Brooks PM. Hematopoietic stem cell transplantation in rheumatic diseases. Curr Opin Rheumatol 1999;11:167-72.
18. 18 Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Br J Rheumatol 1997;36:390-2.
19. 19 Drakos PE, Nagler A, Or R. Case of Crohn's disease in bone marrow transplantation. Am J Hematol 1993;43:157-8.
20. 20 Castro J, Benich HI, Smith L, et al. Prolonged clinical remission in patients (pts) with inflammatory bowel disease (IBD) after high dose chemotherapy (HDC) and autologous blood stem cell transplantation. Blood 1996;88: 133A.
21. 21 Yin JA, Jowitt SN. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 1992;9:31-3.
22. 22 Spiers AS. Ulcerative colitis after bone-marrow transplantation for acute leukemia. N Engl J Med 1984;311:1259.
23. 23 Murayama T, Nakagawa T, Matsushita K, et al. Hemorrhagic colitis with unusual colonoscopy features, complicated with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995;15:141-3.
24. 24 Eigenbrodt ML, Eigenbrodt EH, Thiele DL. Histologic similarity of murine colonic graft-versus-host disease (GVHD) to human colonic GVHD and inflammatory bowel disease. Am J Pathol 1990;137:1065-76.
25. 25 James SP. Allogeneic bone marrow transplantation in Crohn's disease. Gastroenterology 1998;114:596-8.
26. 26 Katz KD, Hollander D, Vadheim CM, et al. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 1989;97:927-31.
27. 27 Soderholm JD, Olaison G, Lindberg E, et al. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence? Gut 1999;44:96-100.
28. 28 De Vries EGE, Willemse PHB, Biesma B, Stern AC, Limburg PC, Vellenga E. Flare up of rheumatoid arthritis during GM-CSF treatment after chemotherapy. Lancet 1991;338:517-8.
29. 29 Snowden JA, Biggs JC, Milliken ST, Fuller A, Staniforth D, Passuello F. A randomised, blinded, placebo-controlled, dose escalation study of tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplantat 1998;22:1035-41.
30. 30 Tyndall A, Fassas A, Passweg J, et al. Autologous haemopoietic stem cell transplants for autoimmune disease - feasibility and transplant related mortality. Bone Marrow Transplant 1999;24:729-34.
31. 31 Travis SP. Review article: insurance risks for patients with ulcerative colitis or Crohn's disease. Aliment Pharmacol Ther 1997;11:51-9.
32. 32 Snowden JA, Nivison-Smith I, Biggs JC, Brooks PM. Risk taking in patients with rheumatoid arthritis: are the risks of haemopoietic stem cell transplantation acceptable? Rheumatology 1999;38:321-4.
33. 33 Zujewski J, Nelson A, Abrams J. Much ado about not... enough data: high-dose chemotherapy with autologous stem cell rescue for breast cancer. J Natl Cancer Inst 1998;90:200-9.
34. 34 Backman CL, Harris SR. Case studies, single-subject research, and N of 1 randomized trials: comparisons and contrasts. Am J Phys Med Rehabil 1999;78:170-6.
35. 35 Fisher LD. Self-designing clinical trials. Stat Med 1998;17:1551-62.
36. 36 Posthuma EF, Westendorp RG, van der Sluys Veer A, Kluin-Nelemans JC, Kluin PM, Lamers CB. Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine. Gut 1995;36:311-13
37. 37 Sartor RB. Review article: Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment Pharmacol Ther 1997; 11(suppl 3):17-22.
38. 38 Turunen UM, Farkkila MA, Hakala K, et al. Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study. Gastroenterology 1998;115:1072-8.